Your search for non small cell lung cancer returned 493 results

Your search for non small cell lung cancer returned 493 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

PARP Inhibitor Veliparib Gets Orphan Drug Status from FDA

AbbVie announced that the Food and Drug Administration (FDA) has granted Orphan Drug Designation to veliparib, an investigational combination with chemotherapies or radiation for the treatment of advanced squamous non-small cell lung cancer (NSCLC).
Drugs in the Pipeline

Positive Outcomes Observed with Xalkori in NSCLC Study

Pfizer announced results from PROFILE 1014, a Phase 3 study of Xalkori (crizotinib) in previously untreated patients with anaplastic lymphoma kinase (ALK)-positive advanced non-squamous non-small cell lung cancer (NSCLC).
Generics News

Dr. Reddy’s Launches Generic Taxotere

Dr. Reddy's Laboratories announced the launch of Docetaxel Injection, the generic version of Sanofi Aventis' Taxotere.
Drugs in the Pipeline

AbbVie Launches Veliparib Trial for NSCLC

AbbVie announced the initiation of a Phase 3 trial evaluating the safety and efficacy of veliparib (ABT-888) in patients with previously untreated locally advanced or metastatic squamous non-small cell lung cancer (NSCLC).
News

New Targeted Tx for Metastatic NSCLC Launched

AstraZeneca announced the launch of Tagrisso (osimertinib) for treatment of metastatic EGFR T790M mutation-positive non-small cell lung cancer (NSCLC).